{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T16:47:51Z","timestamp":1791478071309,"version":"4.3.4"},"reference-count":85,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,4,16]],"date-time":"2025-04-16T00:00:00Z","timestamp":1744761600000},"content-version":"am","delay-in-days":289,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100023300","name":"Pasteur Institute of Tunis","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100023300","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cytokine"],"published-print":{"date-parts":[[2024,7]]},"DOI":"10.1016\/j.cyto.2024.156617","type":"journal-article","created":{"date-parts":[[2024,4,16]],"date-time":"2024-04-16T20:48:11Z","timestamp":1713300491000},"page":"156617","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"special_numbering":"C","title":["Increased IL-22 in cerebrospinal fluid of neuro-beh\u00e7et\u2019s disease patients"],"prefix":"10.1016","volume":"179","author":[{"given":"Meriam","family":"Belghith","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olfa","family":"Maghrebi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rafika","family":"Ben Laamari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mariem","family":"Hanachi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sana","family":"Hrir","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zakaria","family":"Saied","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samir","family":"Belal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adel","family":"Driss","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samia","family":"Ben Sassi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thouraya","family":"Boussoffara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohamed-Ridha","family":"Barbouche","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.cyto.2024.156617_b0005","doi-asserted-by":"crossref","unstructured":"Caruso P, Moretti R. Focus on neuro-Beh\u00e7et\u2019s disease: A review [Internet]. Vol. 66, Neurology India. 2018. p. 1619. Available from: doi: 10.4103\/0028-3886.246252.","DOI":"10.4103\/0028-3886.246252"},{"issue":"2","key":"10.1016\/j.cyto.2024.156617_b0010","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/S1474-4422(17)30470-2","article-title":"Diagnosis of multiple sclerosis: 2017 revisions of the McDonald criteria","volume":"17","author":"Thompson","year":"2018","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.cyto.2024.156617_b0015","doi-asserted-by":"crossref","unstructured":"(itr-Icbd) ITFTR of TICFBD, International Team for the Revision of the International Criteria for Beh\u00e7et\u2019s Disease (ITR-ICBD), Davatchi F, Assaad-Khalil S, Calamia KT, Crook JE, et al. The International Criteria for Beh\u00e7et\u2019s Disease (ICBD): a collaborative study of 27 countries on the sensitivity and specificity of the new criteria [Internet]. Vol. 28, Journal of the European Academy of Dermatology and Venereology. 2014. p. 338\u201347. Available from: doi: 10.1111\/jdv.12107.","DOI":"10.1111\/jdv.12107"},{"issue":"6 Suppl 94","key":"10.1016\/j.cyto.2024.156617_b0020","first-page":"S80","article-title":"Beh\u00e7et\u2019s disease patients with multiple sclerosis-like features: discriminative value of Barkhof criteria","volume":"33","author":"Akman-Demir","year":"2015","journal-title":"Clin. Exp. Rheumatol."},{"issue":"2012","key":"10.1016\/j.cyto.2024.156617_b0025","article-title":"Is multiple sclerosis an autoimmune disease?","volume":"16","author":"Wootla","year":"2012","journal-title":"Autoimmune Dis."},{"issue":"1\u20132","key":"10.1016\/j.cyto.2024.156617_b0030","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.jneuroim.2006.07.006","article-title":"Oligoclonal bands in multiple sclerosis cerebrospinal fluid: an update on methodology and clinical usefulness","volume":"180","author":"Link","year":"2006","journal-title":"J. Neuroimmunol."},{"issue":"5","key":"10.1016\/j.cyto.2024.156617_b0035","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1038\/ni.1716","article-title":"C-C chemokine receptor 6-regulated entry of TH-17 cells into the CNS through the choroid plexus is required for the initiation of EAE","volume":"10","author":"Reboldi","year":"2009","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.cyto.2024.156617_b0040","doi-asserted-by":"crossref","unstructured":"Murphy \u00c1C, Lalor SJ, Lynch MA, Mills KHG. Infiltration of Th1 and Th17 cells and activation of microglia in the CNS during the course of experimental autoimmune encephalomyelitis [Internet]. Vol. 24, Brain, Behavior, and Immunity. 2010. p. 641\u201351. Available from: doi: 10.1016\/j.bbi.2010.01.014.","DOI":"10.1016\/j.bbi.2010.01.014"},{"issue":"10","key":"10.1016\/j.cyto.2024.156617_b0045","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.1038\/nm1651","article-title":"Human TH17 lymphocytes promote blood-brain barrier disruption and central nervous system inflammation","volume":"13","author":"Kebir","year":"2007","journal-title":"Nat. Med."},{"issue":"2","key":"10.1016\/j.cyto.2024.156617_b0050","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1177\/135245859900500206","article-title":"Interleukin-17 mRNA expression in blood and CSF mononuclear cells is augmented in multiple sclerosis","volume":"5","author":"Matusevicius","year":"1999","journal-title":"Mult. Scler."},{"issue":"1","key":"10.1016\/j.cyto.2024.156617_b0055","doi-asserted-by":"crossref","first-page":"146","DOI":"10.2353\/ajpath.2008.070690","article-title":"Interleukin-17 Production in Central Nervous System-Infiltrating T Cells and Glial Cells Is Associated with Active Disease in Multiple Sclerosis","volume":"172","author":"Tzartos","year":"2008","journal-title":"Am. J. Pathol."},{"issue":"7152","key":"10.1016\/j.cyto.2024.156617_b0060","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1038\/nature05970","article-title":"IL-21 initiates an alternative pathway to induce proinflammatory TH 17 cells","volume":"448","author":"Korn","year":"2007","journal-title":"Nature"},{"issue":"47","key":"10.1016\/j.cyto.2024.156617_b0065","doi-asserted-by":"crossref","first-page":"18460","DOI":"10.1073\/pnas.0809850105","article-title":"IL-6 controls Th17 immunity in vivo by inhibiting the conversion of conventional T cells into Foxp3+ regulatory T cells","volume":"105","author":"Korn","year":"2008","journal-title":"PNAS"},{"issue":"10","key":"10.1016\/j.cyto.2024.156617_b0070","doi-asserted-by":"crossref","first-page":"4822","DOI":"10.4049\/jimmunol.160.10.4822","article-title":"A critical role for IL-4 in regulating disease severity in experimental allergic encephalomyelitis as demonstrated in IL-4-deficient C57BL\/6 mice and BALB\/c mice","volume":"160","author":"Falcone","year":"1998","journal-title":"J. Immunol."},{"issue":"7","key":"10.1016\/j.cyto.2024.156617_b0075","doi-asserted-by":"crossref","first-page":"2092","DOI":"10.1002\/1521-4141(200007)30:7<2092::AID-IMMU2092>3.0.CO;2-7","article-title":"A novel population of B7\u20131+ T cells producing intracellular IL-4 is decreased in patients with multiple sclerosis","volume":"30","author":"Kipp","year":"2000","journal-title":"Eur. J. Immunol."},{"issue":"11","key":"10.1016\/j.cyto.2024.156617_b0080","doi-asserted-by":"crossref","first-page":"1211","DOI":"10.1007\/s10067-010-1491-6","article-title":"Etiopathogenesis of Beh\u00e7et\u2019s disease with emphasison the role of immunological aberrations","volume":"29","author":"Kapsimali","year":"2010","journal-title":"Clin. Rheumatol."},{"issue":"7","key":"10.1016\/j.cyto.2024.156617_b0085","doi-asserted-by":"crossref","first-page":"3058","DOI":"10.1167\/iovs.07-1390","article-title":"Upregulated IL-23 and IL-17 in Beh\u00e7et patients with active uveitis","volume":"49","author":"Chi","year":"2008","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"issue":"1\u20132","key":"10.1016\/j.cyto.2024.156617_b0090","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/j.jneuroim.2003.08.040","article-title":"Cytokines and chemokines in neuro-Beh\u00e7et\u2019s disease compared to multiple sclerosis and other neurological diseases","volume":"145","author":"Saruhan-Direskeneli","year":"2003","journal-title":"J. Neuroimmunol."},{"issue":"10","key":"10.1016\/j.cyto.2024.156617_b0095","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1016\/j.autrev.2011.12.005","article-title":"Cytokines and Behcet\u2019s disease","volume":"11","author":"Zhou","year":"2012","journal-title":"Autoimmun. Rev."},{"issue":"4","key":"10.1016\/j.cyto.2024.156617_b0100","doi-asserted-by":"crossref","first-page":"139","DOI":"10.2147\/JIR.S25314","article-title":"Transcriptional characteristics of CD4 T cells in young asthmatic children: RORC and FOXP3 axis","volume":"11","author":"Hamzaoui","year":"2011","journal-title":"J. Inflamm. Res."},{"issue":"1","key":"10.1016\/j.cyto.2024.156617_b0105","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1006\/clin.1996.4268","article-title":"Cerebrospinal fluid interleukin-6 in progressive Neuro-Beh\u00e7et\u2019s syndrome","volume":"82","author":"Hirohata","year":"1997","journal-title":"Clin. Immunol. Immunopathol."},{"issue":"8","key":"10.1016\/j.cyto.2024.156617_b0110","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1111\/j.1346-8138.2003.tb00442.x","article-title":"Serum levels of IL-4, IL-10, IL-12, IL-13 and IFN-gamma in Beh\u00e7et\u2019s disease","volume":"30","author":"Aridogan","year":"2003","journal-title":"J. Dermatol."},{"key":"10.1016\/j.cyto.2024.156617_b0115","article-title":"12;11(8)","author":"Maghrebi","year":"2022","journal-title":"Available from:"},{"issue":"4","key":"10.1016\/j.cyto.2024.156617_b0120","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1111\/imm.12583","article-title":"Inverse correlation of expression of microRNA-140-5p with progression of multiple sclerosis and differentiation of encephalitogenic T helper type 1 cells","volume":"147","author":"Guan","year":"2016","journal-title":"Immunology"},{"issue":"10","key":"10.1016\/j.cyto.2024.156617_b0125","doi-asserted-by":"crossref","DOI":"10.1016\/j.autrev.2020.102647","article-title":"The role of TH17 cells in multiple sclerosis: Therapeutic implications","volume":"19","author":"Moser","year":"2020","journal-title":"Autoimmun. Rev."},{"issue":"1","key":"10.1016\/j.cyto.2024.156617_b0130","first-page":"1","article-title":"Expression of chemokine receptors on Th1\/Th2 CD4+ lymphocytes in patients with multiple sclerosis","volume":"8","author":"Andalib","year":"2011","journal-title":"Iran. J. Immunol."},{"issue":"6","key":"10.1016\/j.cyto.2024.156617_b0135","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1056\/NEJMcibr2033544","article-title":"Cells in Multiple Sclerosis","volume":"384","author":"Goverman","year":"2021","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.cyto.2024.156617_b0140","doi-asserted-by":"crossref","unstructured":"Hamzaoui K, Haghighi AB, Ben Ghorbel I, Houman H. RORC and Foxp3 axis in cerebrospinal fluid of patients with Neuro-Beh\u00e7et\u2019s Disease [Internet]. Vol. 233, Journal of Neuroimmunology. 2011. p. 249\u201353. Available from: doi: 10.1016\/j.jneuroim.2011.01.012.","DOI":"10.1016\/j.jneuroim.2011.01.012"},{"issue":"12","key":"10.1016\/j.cyto.2024.156617_b0145","article-title":"Role of Th22 Cells in the Pathogenesis of Autoimmune Diseases","volume":"6","author":"Jiang","year":"2021","journal-title":"Front. Immunol."},{"issue":"3","key":"10.1016\/j.cyto.2024.156617_b0150","first-page":"11","article-title":"Contrasting Roles of IL-22 and IL-17 in Murine Genital Tract Infection by Neisseria gonorrhoeae","volume":"6","author":"Feinen","year":"2012","journal-title":"Front. Immunol."},{"issue":"5","key":"10.1016\/j.cyto.2024.156617_b0155","doi-asserted-by":"crossref","first-page":"2182","DOI":"10.4049\/jimmunol.1601480","article-title":"Th22 Cells Form a Distinct Th Lineage from Th17 Cells In Vitro with Unique Transcriptional Properties and Tbet-Dependent Th1 Plasticity","volume":"198","author":"Plank","year":"2017","journal-title":"J. Immunol."},{"key":"10.1016\/j.cyto.2024.156617_b0160","first-page":"173 p","article-title":"Multiple Implications of the Kynurenine Pathway in Inflammatory Diseases","author":"M\u00e1ndi","year":"2022","journal-title":"Diagnostic and Therapeutic Applications. Frontiers Media SA"},{"issue":"9","key":"10.1016\/j.cyto.2024.156617_b0165","doi-asserted-by":"crossref","first-page":"1662","DOI":"10.1007\/s00415-013-7209-3","article-title":"Diagnosis and management of Neuro-Beh\u00e7et\u2019s disease: international consensus recommendations","volume":"261","author":"Kalra","year":"2014","journal-title":"J. Neurol."},{"issue":"7230","key":"10.1016\/j.cyto.2024.156617_b0170","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1038\/nature07537","article-title":"A human natural killer cell subset provides an innate source of IL-22 for mucosal immunity","volume":"457","author":"Cella","year":"2009","journal-title":"Nature"},{"issue":"33","key":"10.1016\/j.cyto.2024.156617_b0175","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1146\/annurev-immunol-032414-112123","article-title":"Interleukin-22: immunobiology and pathology","volume":"11","author":"Dudakov","year":"2015","journal-title":"Annu. Rev. Immunol."},{"issue":"5","key":"10.1016\/j.cyto.2024.156617_b0180","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1016\/j.cytogfr.2006.09.001","article-title":"Interleukin-22: a novel T- and NK-cell derived cytokine that regulates the biology of tissue cells","volume":"17","author":"Wolk","year":"2006","journal-title":"Cytokine Growth Factor Rev."},{"issue":"2","key":"10.1016\/j.cyto.2024.156617_b0185","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/j.immuni.2004.07.007","article-title":"IL-22 increases the innate immunity of tissues","volume":"21","author":"Wolk","year":"2004","journal-title":"Immunity"},{"issue":"1\u20132","key":"10.1016\/j.cyto.2024.156617_b0190","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1007\/s11010-011-0772-y","article-title":"Th22 in inflammatory and autoimmune disease: prospects for therapeutic intervention","volume":"353","author":"Zhang","year":"2011","journal-title":"Mol. Cell. Biochem."},{"issue":"3","key":"10.1016\/j.cyto.2024.156617_b0195","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1038\/nm1720","article-title":"Interleukin-22 mediates early host defense against attaching and effacing bacterial pathogens","volume":"14","author":"Zheng","year":"2008","journal-title":"Nat. Med."},{"issue":"5","key":"10.1016\/j.cyto.2024.156617_b0200","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1038\/ni.2025","article-title":"Border patrol: regulation of immunity, inflammation and tissue homeostasis at barrier surfaces by IL-22","volume":"12","author":"Sonnenberg","year":"2011","journal-title":"Nat. Immunol."},{"issue":"6","key":"10.1016\/j.cyto.2024.156617_b0205","doi-asserted-by":"crossref","first-page":"1869","DOI":"10.1002\/art.34355","article-title":"Interleukin-22 and interleukin-22-producing NKp44+ natural killer cells in subclinical gut inflammation in ankylosing spondylitis","volume":"64","author":"Ciccia","year":"2012","journal-title":"Arthritis Rheum."},{"issue":"1","key":"10.1016\/j.cyto.2024.156617_b0210","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.cytogfr.2012.07.002","article-title":"Emerging role of interleukin-22 in autoimmune diseases","volume":"24","author":"Pan","year":"2013","journal-title":"Cytokine Growth Factor Rev."},{"issue":"3","key":"10.1016\/j.cyto.2024.156617_b0215","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1111\/j.1365-2249.2007.03511.x","article-title":"A role for T cell-derived interleukin 22 in psoriatic skin inflammation","volume":"150","author":"Boniface","year":"2007","journal-title":"Clin. Exp. Immunol."},{"issue":"2","key":"10.1016\/j.cyto.2024.156617_b0220","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1007\/s00005-018-0527-5","article-title":"Interleukin-22 and Its Correlation with Disease Activity in Plaque Psoriasis","volume":"67","author":"Wawrzycki","year":"2019","journal-title":"Arch. Immunol. Ther. Exp."},{"issue":"3","key":"10.1016\/j.cyto.2024.156617_b0225","doi-asserted-by":"crossref","first-page":"e59009","DOI":"10.1371\/journal.pone.0059009","article-title":"Increased expression of IL-22 is associated with disease activity in Behcet\u2019s disease","volume":"8","author":"Cai","year":"2013","journal-title":"PLoS One"},{"issue":"5","key":"10.1016\/j.cyto.2024.156617_b0230","doi-asserted-by":"crossref","first-page":"802","DOI":"10.3109\/14397595.2013.879414","article-title":"IL-22-secreting Th22 and IFN-\u03b3-secreting Th17 cells in Beh\u00e7et\u2019s disease","volume":"24","author":"Aktas Cetin","year":"2014","journal-title":"Mod. Rheumatol."},{"issue":"11","key":"10.1016\/j.cyto.2024.156617_b0235","doi-asserted-by":"crossref","first-page":"5799","DOI":"10.4049\/jimmunol.1202677","article-title":"Role of IL-22\u2013 and TNF-\u03b1\u2013Producing Th22 Cells in Uveitis Patients with Beh\u00e7et\u2019s Disease","volume":"190","author":"Sugita","year":"2013","journal-title":"J. Immunol."},{"issue":"12","key":"10.1016\/j.cyto.2024.156617_b0240","doi-asserted-by":"crossref","first-page":"3265","DOI":"10.1002\/eji.200838655","article-title":"IL-22 and inflammation: leukin\u2019 through a glass onion","volume":"38","author":"Zenewicz","year":"2008","journal-title":"Eur. J. Immunol."},{"issue":"4","key":"10.1016\/j.cyto.2024.156617_b0245","doi-asserted-by":"crossref","first-page":"1814","DOI":"10.4049\/jimmunol.164.4.1814","article-title":"Cloning and characterization of IL-10-related T cell-derived inducible factor (IL-TIF), a novel cytokine structurally related to IL-10 and inducible by IL-9","volume":"164","author":"Dumoutier","year":"2000","journal-title":"J. Immunol."},{"issue":"12","key":"10.1016\/j.cyto.2024.156617_b0250","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1186\/s12974-015-0335-3","article-title":"Interleukin-22 is increased in multiple sclerosis patients and targets astrocytes","volume":"16","author":"Perriard","year":"2015","journal-title":"J. Neuroinflammation"},{"issue":"1","key":"10.1016\/j.cyto.2024.156617_b0255","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1038\/sj.gene.6364144","article-title":"Is there an interaction between interleukin-10 and interleukin-22?","volume":"6","author":"Wolk","year":"2005","journal-title":"Genes Immun."},{"issue":"5","key":"10.1016\/j.cyto.2024.156617_b0260","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1038\/sj.gene.6364104","article-title":"Cloning of murine IL-22 receptor alpha 2 and comparison with its human counterpart","volume":"5","author":"Weiss","year":"2004","journal-title":"Genes Immun."},{"issue":"6","key":"10.1016\/j.cyto.2024.156617_b0265","doi-asserted-by":"crossref","first-page":"3695","DOI":"10.4049\/jimmunol.174.6.3695","article-title":"IL-22 inhibits epidermal differentiation and induces proinflammatory gene expression and migration of human keratinocytes","volume":"174","author":"Boniface","year":"2005","journal-title":"J. Immunol."},{"issue":"6","key":"10.1016\/j.cyto.2024.156617_b0270","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1016\/j.coi.2007.07.020","article-title":"Th17: the third member of the effector T cell trilogy","volume":"19","author":"Bettelli","year":"2007","journal-title":"Curr. Opin. Immunol."},{"issue":"6","key":"10.1016\/j.cyto.2024.156617_b0275","doi-asserted-by":"crossref","first-page":"1293","DOI":"10.1084\/jem.20092054","article-title":"Pathological versus protective functions of IL-22 in airway inflammation are regulated by IL-17A","volume":"207","author":"Sonnenberg","year":"2010","journal-title":"J. Exp. Med."},{"issue":"1","key":"10.1016\/j.cyto.2024.156617_b0280","doi-asserted-by":"crossref","first-page":"34","DOI":"10.4103\/1110-161X.155646","article-title":"Interleukin-17 in Beh\u00e7et\u2019s disease: relation with clinical picture and disease activity","volume":"42","author":"Al-Zifzaf","year":"2015","journal-title":"Egyptian Rheumatology and Rehabilitation."},{"key":"10.1016\/j.cyto.2024.156617_b0285","doi-asserted-by":"crossref","DOI":"10.1155\/2012\/260473","article-title":"IL-17 and IL-22 in Cerebrospinal Fluid and Plasma Are Elevated in Guillain-Barr\u00e9 Syndrome","author":"Li","year":"2012","journal-title":"Mediators Inflamm [internet]."},{"issue":"11","key":"10.1016\/j.cyto.2024.156617_b0290","doi-asserted-by":"crossref","first-page":"6883","DOI":"10.4049\/jimmunol.1001392","article-title":"IL-22RA2 associates with multiple sclerosis and macrophage effector mechanisms in experimental neuroinflammation","volume":"185","author":"Beyeen","year":"2010","journal-title":"J. Immunol."},{"issue":"7","key":"10.1016\/j.cyto.2024.156617_b0295","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1038\/gene.2014.36","article-title":"The multiple sclerosis risk gene IL22RA2 contributes to a more severe murine autoimmune neuroinflammation","volume":"15","author":"Laaksonen","year":"2014","journal-title":"Genes Immun."},{"issue":"3","key":"10.1016\/j.cyto.2024.156617_b0300","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1093\/intimm\/dxr001","article-title":"Recent advances in IL-22 biology","volume":"23","author":"Zenewicz","year":"2011","journal-title":"Int. Immunol."},{"issue":"3","key":"10.1016\/j.cyto.2024.156617_b0305","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1093\/stmcls\/sxad003","article-title":"IL-22 Promotes Neural Stem Cell Self-Renewal in the Adult Brain","volume":"41","author":"Coronas","year":"2023","journal-title":"Stem Cells"},{"key":"10.1016\/j.cyto.2024.156617_b0310","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.jaut.2019.04.017","article-title":"Interleukin 22 ameliorates neuropathology and protects from central nervous system autoimmunity","volume":"102","author":"Mattapallil","year":"2019","journal-title":"J. Autoimmun."},{"issue":"13","key":"10.1016\/j.cyto.2024.156617_b0315","article-title":"Interleukin 22 and its association with neurodegenerative disease activity","volume":"13","author":"Chen","year":"2022","journal-title":"Front. Pharmacol."},{"issue":"12","key":"10.1016\/j.cyto.2024.156617_b0320","doi-asserted-by":"crossref","first-page":"7090","DOI":"10.4049\/jimmunol.166.12.7090","article-title":"Cloning and characterization of IL-22 binding protein, a natural antagonist of IL-10-related T cell-derived inducible factor\/IL-22","volume":"166","author":"Dumoutier","year":"2001","journal-title":"J. Immunol."},{"issue":"12","key":"10.1016\/j.cyto.2024.156617_b0325","doi-asserted-by":"crossref","first-page":"7096","DOI":"10.4049\/jimmunol.166.12.7096","article-title":"Identification, cloning, and characterization of a novel soluble receptor that binds IL-22 and neutralizes its activity","volume":"166","author":"Kotenko","year":"2001","journal-title":"J. Immunol."},{"issue":"17","key":"10.1016\/j.cyto.2024.156617_b0330","doi-asserted-by":"crossref","first-page":"9511","DOI":"10.1073\/pnas.171303198","article-title":"A soluble class II cytokine receptor, IL-22RA2, is a naturally occurring IL-22 antagonist","volume":"98","author":"Xu","year":"2001","journal-title":"PNAS"},{"issue":"4","key":"10.1016\/j.cyto.2024.156617_b0335","doi-asserted-by":"crossref","first-page":"888","DOI":"10.4049\/jimmunol.1900400","article-title":"IL-22 Binding Protein Promotes the Disease Process in Multiple Sclerosis","volume":"203","author":"Lindahl","year":"2019","journal-title":"J. Immunol."},{"issue":"7","key":"10.1016\/j.cyto.2024.156617_b0340","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1177\/1352458512468497","article-title":"Serum levels of IL-17A in patients with relapsing-remitting multiple sclerosis treated with interferon-\u03b2","volume":"19","author":"B\u0103la\u015fa","year":"2013","journal-title":"Mult. Scler."},{"issue":"3","key":"10.1016\/j.cyto.2024.156617_b0345","doi-asserted-by":"crossref","first-page":"e0173780","DOI":"10.1371\/journal.pone.0173780","article-title":"IL-22, GM-CSF and IL-17 in peripheral CD4+ T cell subpopulations during multiple sclerosis relapses and remission","volume":"12","author":"Muls","year":"2017","journal-title":"Impact of Corticosteroid Therapy. Plos One."},{"issue":"10","key":"10.1016\/j.cyto.2024.156617_b0350","doi-asserted-by":"crossref","first-page":"1172","DOI":"10.1177\/1352458519852092","article-title":"T cells producing GM-CSF and IL-13 are enriched in the cerebrospinal fluid of relapsing MS patients","volume":"26","author":"Ghezzi","year":"2020","journal-title":"Mult. Scler."},{"issue":"10","key":"10.1016\/j.cyto.2024.156617_b0355","doi-asserted-by":"crossref","first-page":"2271","DOI":"10.1084\/jem.20061308","article-title":"Interleukin (IL)-22 and IL-17 are coexpressed by Th17 cells and cooperatively enhance expression of antimicrobial peptides","volume":"203","author":"Liang","year":"2006","journal-title":"J. Exp. Med."},{"issue":"12","key":"10.1016\/j.cyto.2024.156617_b0360","doi-asserted-by":"crossref","first-page":"1238","DOI":"10.1038\/ni.2134","article-title":"Transcription factor c-Maf mediates the TGF-\u03b2-dependent suppression of IL-22 production in TH17 cells","volume":"12","author":"Rutz","year":"2011","journal-title":"Nat. Immunol."},{"issue":"5","key":"10.1016\/j.cyto.2024.156617_b0365","doi-asserted-by":"crossref","first-page":"1373","DOI":"10.1038\/jid.2009.399","article-title":"Circulating Th17, Th22, and Th1 cells are increased in psoriasis","volume":"130","author":"Kagami","year":"2010","journal-title":"J, Invest. Dermatol."},{"issue":"10","key":"10.1016\/j.cyto.2024.156617_b0370","doi-asserted-by":"crossref","first-page":"665","DOI":"10.3389\/fimmu.2019.00665","volume":"29","author":"Tong","year":"2019","journal-title":"Immunopathogenesis of Behcet\u2019s Disease. Front Immunol."},{"issue":"2","key":"10.1016\/j.cyto.2024.156617_b0375","first-page":"123","article-title":"Monoclonal gammopathies and the related autoimmune manifestations in Taiwan","volume":"10","author":"Wang","year":"1992","journal-title":"Asian Pac. J. Allergy Immunol."},{"key":"10.1016\/j.cyto.2024.156617_b0380","doi-asserted-by":"crossref","unstructured":"Hamzaoui K, Hamzaoui A, Ghorbel I, Khanfir M, Houman H. Levels of IL-15 in Serum and Cerebrospinal Fluid of Patients with Beh\u00e7et\u2019s Disease [Internet]. Vol. 64, Scandinavian Journal of Immunology. 2006. p. 655\u201360. Available from: doi: 10.1111\/j.1365-3083.2006.01844.x.","DOI":"10.1111\/j.1365-3083.2006.01844.x"},{"issue":"6","key":"10.1016\/j.cyto.2024.156617_b0385","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1016\/j.clineuro.2009.02.001","article-title":"CSF levels of cytokines in neuro-Beh\u00e7et\u2019s disease","volume":"111","author":"Borhani Haghighi","year":"2009","journal-title":"Clin. Neurol. Neurosurg."},{"issue":"23","key":"10.1016\/j.cyto.2024.156617_b0390","doi-asserted-by":"crossref","first-page":"e3550","DOI":"10.1097\/MD.0000000000003550","article-title":"Efficacy of Anti-TNF\u03b1 in Severe and Refractory Neuro-Behcet Disease: An Observational Study","volume":"95","author":"Desbois","year":"2016","journal-title":"Medicine"},{"key":"10.1016\/j.cyto.2024.156617_b0395","article-title":"29;11(15)","author":"Belghith","year":"2022","journal-title":"Available from:"},{"issue":"8","key":"10.1016\/j.cyto.2024.156617_b0400","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1038\/ni.1767","article-title":"Production of interleukin 22 but not interleukin 17 by a subset of human skin-homing memory T cells","volume":"10","author":"Duhen","year":"2009","journal-title":"Nat. Immunol."},{"issue":"12","key":"10.1016\/j.cyto.2024.156617_b0405","first-page":"3573","article-title":"Th22 cells represent a distinct human T cell subset involved in epidermal immunity and remodeling","volume":"119","author":"Eyerich","year":"2009","journal-title":"J. Clin. Invest."},{"issue":"12","key":"10.1016\/j.cyto.2024.156617_b0410","article-title":"Differential Gene Expression Patterns in Blood and Cerebrospinal Fluid of Multiple Sclerosis and Neuro-Beh\u00e7et Disease","volume":"26","author":"Maghrebi","year":"2021","journal-title":"Front. Genet."},{"key":"10.1016\/j.cyto.2024.156617_b0415","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1016\/j.cyto.2018.03.039","article-title":"Cerebrospinal fluid IL-10 as an early stage discriminative marker between multiple sclerosis and neuro-Beh\u00e7et disease","volume":"108","author":"Belghith","year":"2018","journal-title":"Cytokine"},{"key":"10.1016\/j.cyto.2024.156617_b0420","doi-asserted-by":"crossref","unstructured":"Bahrini K, Belghith M, Maghrebi O, Bekir J, Kchaou M, Jeridi C, et al. Discriminative expression of CD39 and CD73 in Cerebrospinal fluid of patients with Multiple Sclerosis and Neuro-Beh\u00e7et\u2019s disease [Internet]. Vol. 130, Cytokine. 2020. p. 155054. Available from: doi: 10.1016\/j.cyto.2020.155054.","DOI":"10.1016\/j.cyto.2020.155054"},{"issue":"4","key":"10.1016\/j.cyto.2024.156617_b0425","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1002\/acn3.538","article-title":"CSF\/serum matrix metallopeptidase-9 ratio discriminates neuro Beh\u00e7et from multiple sclerosis","volume":"5","author":"Aldinucci","year":"2018","journal-title":"Ann. Clin. Transl. Neurol."}],"container-title":["Cytokine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1043466624001200?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1043466624001200?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,6,18]],"date-time":"2024-06-18T22:00:36Z","timestamp":1718748036000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1043466624001200"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,7]]},"references-count":85,"alternative-id":["S1043466624001200"],"URL":"https:\/\/doi.org\/10.1016\/j.cyto.2024.156617","relation":{},"ISSN":["1043-4666"],"issn-type":[{"value":"1043-4666","type":"print"}],"subject":[],"published":{"date-parts":[[2024,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Increased IL-22 in cerebrospinal fluid of neuro-beh\u00e7et\u2019s disease patients","name":"articletitle","label":"Article Title"},{"value":"Cytokine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cyto.2024.156617","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"156617"}}